- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02765542
Developing Accessible mHealth Programs for Depression Management in Bolivia
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
All patients will receive a weekly 10-15 minute automated phone call to their cell phone for disease assessment and self-care support for up to 12 weeks. During enrollment, the research team will explain how to use the automated phone system. During patients' automated calls, they will be asked questions about their self-care relevant to their diagnosis, symptoms of depression, and medication adherence (if patients are prescribed an anti-depressant). Based on the patient's self-report, they will receive targeted suggestions for how to improve their self-management. At the end of each automated call, patients will hear the phone number of their clinic, which they can call for a health problem or to disenroll from the program. At the time of recruitment, if possible, an initial automated call will be sent to the patient's phone so that they can learn what to expect and have the chance to ask questions of the research associate who will be present.
In the event that the patient reports a health or self-care problem during their call (i.e., the patient reports rarely or never taking their medication), a report will automatically be generated and sent by email to the research team plus the patient's designated clinician so that follow-up can take place. The secure email address will be verified with each clinician, and be password protected.
The intervention will last up to 12 weeks, after which the patient will have a follow-up meeting with the research team and will complete a survey about the program. All follow-ups will take place either in person or over the phone.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
La Paz, Bolivia
- El Servicio Departmental de Salud (SEDES) affiliated clinics
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- 21-80 years of age
- PHQ-8 score of 10 or higher
Exclusion Criteria:
- Have diagnoses indicating a six-month life expectancy
- Prior inpatient psychiatric treatment
- Patients with probable bipolar disorder or cognitive impairment as indicated on validated screeners
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Automated phone calls
Automated disease assessment & self-care support phone calls for up to 12 weeks.
|
Automated disease assessment & self-care support phone calls for up to 12 weeks.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Change from baseline on depressive symptoms at 12 weeks (PHQ-8 Scores)
Periodo de tiempo: Baseline and 12 week post-intervention follow-up
|
Baseline and 12 week post-intervention follow-up
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Change from baseline on self-care behaviors at 12 weeks (self-care behavior questionnaire)
Periodo de tiempo: Baseline and 12 week post-intervention follow-up
|
Baseline and 12 week post-intervention follow-up
|
|
Evaluate program feasibility (telephone call completion rates)
Periodo de tiempo: 12 week post-intervention follow-up
|
12 week post-intervention follow-up
|
|
Patient satisfaction (satisfaction questionnaire)
Periodo de tiempo: 12 week Post-intervention follow-up
|
12 week Post-intervention follow-up
|
|
Patient qualitative feedback (qualitative questionnaire)
Periodo de tiempo: 12 week Post-intervention follow-up
|
12 week Post-intervention follow-up
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: John D Piette, PhD, University of Michigan
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- HUM00087937
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .